These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 35390085)

  • 41. An epidemic of uncertainty: rumors, conspiracy theories and vaccine hesitancy.
    Pertwee E; Simas C; Larson HJ
    Nat Med; 2022 Mar; 28(3):456-459. PubMed ID: 35273403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlates of COVID-19 vaccine hesitancy in Austria: trust and the government.
    Schernhammer E; Weitzer J; Laubichler MD; Birmann BM; Bertau M; Zenk L; Caniglia G; Jäger CC; Steiner G
    J Public Health (Oxf); 2022 Mar; 44(1):e106-e116. PubMed ID: 33948665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trusting COVID-19 vaccines as individual and social goal.
    Falcone R; Ansani A; Colì E; Marini M; Sapienza A; Castelfranchi C; Paglieri F
    Sci Rep; 2022 Jun; 12(1):9470. PubMed ID: 35676518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreasing neutralization antibody levels following vaccination against SARS-CoV-2 in the elderly: an observational study in Southern Moravia, Czech Republic.
    Mravčík V; Husa P; Kumpanová Valachovičová S; Vobořil J
    Epidemiol Mikrobiol Imunol; 2022; 71(1):9-20. PubMed ID: 35477266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
    Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA
    Front Public Health; 2021; 9():709369. PubMed ID: 34368071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.
    Sønderskov KM; Dinesen PT; Østergaard SD
    Dan Med J; 2021 Mar; 68(5):. PubMed ID: 33870886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Building public trust: a response to COVID-19 vaccine hesitancy predicament.
    Vergara RJD; Sarmiento PJD; Lagman JDN
    J Public Health (Oxf); 2021 Jun; 43(2):e291-e292. PubMed ID: 33454769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs.
    Qunaibi EA; Helmy M; Basheti I; Sultan I
    Elife; 2021 May; 10():. PubMed ID: 34042047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Individual preferences for COVID-19 vaccination in China.
    Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
    Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccine nationalism: a predicament in ending the COVID-19 pandemic.
    Lagman JDN
    J Public Health (Oxf); 2021 Jun; 43(2):e375-e376. PubMed ID: 33730161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal.
    Chan NN; Ong KW; Siau CS; Lee KW; Peh SC; Yacob S; Chia YC; Seow VK; Ooi PB
    BMC Public Health; 2022 Feb; 22(1):296. PubMed ID: 35164734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study.
    Wu J; Li Q; Silver Tarimo C; Wang M; Gu J; Wei W; Ma M; Zhao L; Mu Z; Miao Y
    Front Immunol; 2021; 12():781161. PubMed ID: 34912346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021.
    Bajema KL; Dahl RM; Evener SL; Prill MM; Rodriguez-Barradas MC; Marconi VC; Beenhouwer DO; Holodniy M; Lucero-Obusan C; Brown ST; Tremarelli M; Epperson M; Mills L; Park SH; Rivera-Dominguez G; Morones RG; Ahmadi-Izadi G; Deovic R; Mendoza C; Jeong C; Schrag SJ; Meites E; Hall AJ; Kobayashi M; McMorrow M; Verani JR; Thornburg NJ; Surie D; ; ;
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1700-1705. PubMed ID: 34882654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A flexible age-dependent, spatially-stratified predictive model for the spread of COVID-19, accounting for multiple viral variants and vaccines.
    Schneider KA; Tsoungui Obama HCJ; Adil Mahmoud Yousif N
    PLoS One; 2023; 18(1):e0277505. PubMed ID: 36662784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Twitter sentiment analysis from Iran about COVID 19 vaccine.
    Bokaee Nezhad Z; Deihimi MA
    Diabetes Metab Syndr; 2022 Jan; 16(1):102367. PubMed ID: 34933273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany's AstraZeneca controversy.
    Priebe J; Silber H; Beuthner C; Pötzschke S
    BMC Public Health; 2022 Mar; 22(1):516. PubMed ID: 35296289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors and reasons associated with low COVID-19 vaccine uptake among highly hesitant communities in the US.
    Khairat S; Zou B; Adler-Milstein J
    Am J Infect Control; 2022 Mar; 50(3):262-267. PubMed ID: 34995722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
    Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S
    Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.